We are live on
!
Find out more
GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
This Quarter
Est. Return
-19.73%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.41B
AUM Growth
-$431M
(-23%)
Cap. Flow
-$49.9M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
24.85%
Holding
216
New
15
Increased
64
Reduced
101
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paylocity
PCTY
|
+$13.6M |
| 2 |
Azenta
AZTA
|
+$12.2M |
| 3 |
COUP
Coupa Software Incorporated
COUP
|
+$11.4M |
| 4 |
JBTM
JBT Marel
JBTM
|
+$11.4M |
| 5 |
WW
WW International
WW
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SODA
SodaStream International Ltd
SODA
|
+$42.2M |
| 2 |
MB
MINDBODY, Inc. Class A Common Stock
MB
|
+$13.7M |
| 3 |
Strategic Education
STRA
|
+$12.1M |
| 4 |
EVBG
Everbridge, Inc. Common Stock
EVBG
|
+$11.4M |
| 5 |
EBIX
Ebix Inc
EBIX
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.67% |
| 2 | Healthcare | 21.97% |
| 3 | Industrials | 15.66% |
| 4 | Consumer Discretionary | 8.08% |
| 5 | Consumer Staples | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IOTS
151
DELISTED
Adesto Technologies Corp
IOTS
| $1.37M | 0.1% |
310,998
+31,675
| +11% | +$151K |
|
152
CryoPort
CYRX
$762M
| $1.33M | 0.09% |
120,414
-2,342
| -2% | -$25.5K |
|
153
Editas Medicine
EDIT
$442M
| $1.28M | 0.09% |
56,153
-19,904
| -26% | -$542K |
|
|
ITRM
154
DELISTED
Iterum Therapeutics
ITRM
| $1.23M | 0.09% |
16,420
-294
| -2% | -$27.8K |
|
|
NVTR
155
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $1.22M | 0.09% |
74,830
+23,730
| +46% | +$454K |
|
|
ZAGG
156
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $1.22M | 0.09% |
124,699
+39,557
| +46% | +$446K |
|
|
PFIE
157
DELISTED
Profire Energy, Inc
PFIE
| $1.22M | 0.09% |
839,429
-16,314
| -2% | -$38K |
|
|
SGMO
158
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.19M | 0.08% |
104,017
-39,250
| -27% | -$488K |
|
|
GWR
159
DELISTED
Genesee & Wyoming Inc.
GWR
| $1.18M | 0.08% |
16,000
-9,700
| -38% | -$777K |
|
160
Akamai
AKAM
$15.9B
| $1.12M | 0.08% |
18,309
+837
| +5% | +$55.7K |
|
|
VG
161
DELISTED
Vonage Holdings Corporation
VG
| $1.11M | 0.08% |
127,547
-59,692
| -32% | -$684K |
|
|
CDTX
162
DELISTED
Cidara Therapeutics
CDTX
| $1.11M | 0.08% |
23,586
-421
| -2% | -$30K |
|
163
Trupanion
TRUP
$1.18B
| $1.07M | 0.08% |
42,131
-11,369
| -21% | -$306K |
|
164
Larimar Therapeutics
LRMR
$432M
| $1.05M | 0.07% |
17,751
-311
| -2% | -$30.7K |
|
165
CRISPR Therapeutics
CRSP
$5.17B
| $1M | 0.07% |
34,992
-12,350
| -26% | -$429K |
|
166
Spero Therapeutics
SPRO
$73M
| $949K | 0.07% |
154,306
-2,752
| -2% | -$22.3K |
|
|
RP
167
DELISTED
RealPage, Inc.
RP
| $931K | 0.07% |
+19,325
| New | +$1.01M |
|
|
SOHO
168
DELISTED
Sotherly Hotels
SOHO
| $927K | 0.07% |
165,305
-3,161
| -2% | -$21.2K |
|
|
PRTK
169
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $926K | 0.07% |
180,510
-3,105
| -2% | -$23.6K |
|
170
Intellia Therapeutics
NTLA
$1.67B
| $830K | 0.06% |
60,834
-21,525
| -26% | -$400K |
|
171
Match Group
MTCH
$8.55B
| $767K | 0.05% |
17,928
+6,659
| +59% | +$306K |
|
|
HA
172
DELISTED
Hawaiian Holdings, Inc.
HA
| $692K | 0.05% |
26,206
-129,861
| -83% | -$4.4M |
|
|
VIVE
173
DELISTED
VIVEVE MED INC
VIVE
| $655K | 0.05% |
624
-12
| -2% | -$28.8K |
|
|
ENSV
174
DELISTED
Enservco Corp.
ENSV
| $595K | 0.04% |
107,191
-2,081
| -2% | -$19.3K |
|
|
ETTX
175
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $594K | 0.04% |
+145,844
| New | +$961K |
|
Similar funds
HBT
BC
SW
WFMPM
AG
TA
ACP
TP
Granahan Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, Granahan Investment Management held 216 positions worth $1.41B, down 23% from $1.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Granahan Investment Management withdrew a net $49.9M in Q4 2018, closing 23 positions and reducing 101 holdings. Its most notable exit was SodaStream International Ltd, an estimated $42.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Granahan Investment Management opened a new position in JBT Marel worth $9.22M.
- Granahan Investment Management's largest Q4 2018 buy was JBT Marel: 128,350 shares worth $9.22M.
- Granahan Investment Management added most to Paylocity in Q4 2018, an estimated $13.6M increase.
- Granahan Investment Management's biggest Q4 2018 reduction was Strategic Education, cutting an estimated $12.1M.
- Granahan Investment Management fully exited SodaStream International Ltd in Q4 2018, selling an estimated $42.2M.
- Granahan Investment Management's ten largest holdings make up 25% of its $1.41B portfolio in Q4 2018.
- Granahan Investment Management opened 15 new positions and closed 23 in Q4 2018.
- Granahan Investment Management's portfolio value fell 23% quarter-over-quarter to $1.41B.
Based on Granahan Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.